Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Borg Åke) srt2:(2005-2009)"

Sökning: WFRF:(Borg Åke) > (2005-2009)

Sortera/gruppera träfflistan
  • Augsten, Martin, et al. (författare)
  • CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
  • 2009
  • Ingår i: Proceedings of the National Academy of Sciences of the United States of America. - 0027-8424 .- 1091-6490. ; 106:9, s. 3414-3419
  • Tidskriftsartikel (refereegranskat)abstract
    • This study explored the role of secreted fibroblast-derived factors in prostate cancer growth. Analyses of matched normal and tumor tissue revealed up-regulation of CXCL14 in cancer-associated fibroblasts of a majority of prostate cancer. Fibroblasts over-expressing CXCL14 promoted the growth of prostate cancer xenografts, and increased tumor angiogenesis and macrophage infiltration. Mechanistic studies demonstrated that autocrine CXCL14-stimulation of fibroblasts stimulate migration and ERK-dependent proliferation of fibroblasts. CXCL14-stimulation of monocyte migration was also demonstrated. Furthermore, CXCL14-producing fibroblasts, but not recombinant CXCL14, enhanced in vitro proliferation and migration of prostate cancer cells and in vivo angiogenesis. These studies thus identify CXCL14 as a novel autocrine stimulator of fibroblast growth and migration, with multi-modal tumor-stimulatory activities. In more general terms, our findings suggest autocrine stimulation of fibroblasts as a previously unrecognized mechanism for chemokine-mediated stimulation of tumor growth, and suggest a novel mechanism whereby cancer-associated fibroblasts achieve their pro-tumorigenic phenotype.
  • Carvalho, Marcelo, et al. (författare)
  • Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1
  • 2009
  • Ingår i: Mutation Research. - Elsevier. - 1873-135X. ; 660:1-2, s. 1-11
  • Tidskriftsartikel (refereegranskat)abstract
    • Germline Mutations that inactivate BRCA1 are responsible for breast and ovarian cancer Susceptibility. one possible outcome of genetic testing for BRCA1 is the finding of a genetic variant of uncertain significance for which there is no information regarding its cancer association. This outcome leads to problems ill risk assessment, Counseling and preventive care. The purpose of the present study was to functionally evaluate seven unclassified Variants of BRCA1 including a genomic deletion that leads to the in-frame loss of exons 16/17 (A exons 16/17) in the mRNA. all insertion that leads to a frameshift and all extended carboxy-terminus (5673insC), and five missense variants (K]487R, S1613C, M16521. Q1826H and V1833M). We analyzed the variants using a functional assay based oil the transcription activation property of BRCA1 combined with Supervised learning computational models. Functional analysis indicated that variants S1613C, Q1826H, and M16521 are likely to be neutral, whereas variants V1833M, A exons 16/17, and 5673insCare likely to represent deleterious variants. In agreement with the functional analysis,the results of the computational analysis also indicated that the latter three variants are likely to be deleterious. Taken together, a combined approach of functional and bioinformatics analysis, Plus Structural modeling, can be utilized to Obtain Valuable information pertaining to the effect of a rare variant oil the structure and function of BRCA1. Such information call, in turn,aid in the classification of BRCA1 variants for which there is a lack of genetic information needed to provide reliable risk assessment. (c) 2008 Elsevier B.V. All rights reserved.
  • Davidsson, Josef, et al. (författare)
  • Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3
  • 2007
  • Ingår i: Human Molecular Genetics. - Oxford University Press. - 0964-6906. ; 16:18, s. 2215-2225
  • Tidskriftsartikel (refereegranskat)abstract
    • Although gain of 1q occurs in 25% of Burkitt lymphomas (BLs) and 10% of pediatric high hyperdiploid acute lymphoblastic leukemias (ALLs), little is known about the origin, molecular genetic characteristics and functional outcome of dup(1q) in these disorders. Ten dup(1q)-positive BLs/ALLs were investigated by tiling resolution (32k) array CGH analysis, which revealed that the proximal breakpoints in all cases were near-centromeric, in eight of them clustering within a 1.4 Mb segment in 1q12-21.1. The 1q distal breakpoints were heterogeneous, being more distal in the ALLs than in the BLs. The minimally gained segments in the ALLs and BLs were 57.4 Mb [dup(1)(q22q32.3)] and 35 Mb [dup(1)(q12q25.2)], respectively. Satellite 11 DNA on 1q was not hypomethylated, as ascertained by Southern blot analyses of 15 BLs/ALLs with and without gain of 1q, indicating that aberrant methylation was not involved in the origin of dup(1q), as previously suggested for other neoplasms with 1q rearrangements. Global gene expression analyses revealed that five genes in the minimally 57.4 Mb gained region-B4GALT3, DAP3, RGS16, TMEM183A and UCK2-were significantly overexpressed in dup(1q)-positive ALLs compared with high hyperdiploid ALLs without dup(1q). The DAP3 and UCK2 genes were among the most overexpressed genes in the BL case with gain of 1q investigated. The DAP3 protein has been reported to be highly expressed in invasive glioblastoma multiforme cells, whereas expression of the UCK2 protein has been correlated with sensitivity to anticancer drugs. However, involvement of these genes in dup(1q)-positive ALLs and BLs has previously not been reported.
  • Fernebro, Josefin, et al. (författare)
  • Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma
  • 2006
  • Ingår i: International Journal of Cancer. - John Wiley & Sons. - 0020-7136. ; 118:5, s. 1165-1172
  • Tidskriftsartikel (refereegranskat)abstract
    • We applied 27k spotted cDNA microarray slides to assess gene expression profiles in 26 samples from 24 patients with synovial sarcomas (SS). The data were analyzed in relation to histopathologic type, cytogenetic aberrations, gene fusion type and development of distant metastases. Supervised analysis based on gene fusion type in 12 SS with SS18/SSXI and 9 with SS18/SSX2 revealed significant differences in gene expression profiles. Among the discriminators were several genes that have previously been found to be upregulated in SS, including AXL, ZIC2, SPAG7, AGRN, FOXC1, NCAM1 and multiple metallothioneins. Histopathology and degree of cytogenetic complexity did not significantly influence expression, whereas a genetic signature that related to development of metastases could be discerned, albeit with a high false-positive rate. In conclusion, our findings demonstrate differentially expressed genes for the 2 major gene fusion variants in SS, SS18/SSX1 and SS18/SSX2, and thereby suggest that these result in different downstream effects. (c) 2005 Wiley-Liss, Inc.
  • Gunnarsson, Rebeqa, et al. (författare)
  • Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-A comparative study of four differently designed, high resolution microarray platforms.
  • 2008
  • Ingår i: Genes, Chromosomes and Cancer. - John Wiley & Sons. - 1045-2257. ; 47:8, s. 697-711
  • Tidskriftsartikel (refereegranskat)abstract
    • Screening for gene copy-number alterations (CNAs) has improved by applying genome-wide microarrays, where SNP arrays also allow analysis of loss of heterozygozity (LOH). We here analyzed 10 chronic lymphocytic leukemia (CLL) samples using four different high-resolution platforms: BAC arrays (32K), oligonucleotide arrays (185K, Agilent), and two SNP arrays (250K, Affymetrix and 317K, Illumina). Cross-platform comparison revealed 29 concordantly detected CNAs, including known recurrent alterations, which confirmed that all platforms are powerful tools when screening for large aberrations. However, detection of 32 additional regions present in 2-3 platforms illustrated a discrepancy in detection of small CNAs, which often involved reported copy-number variations. LOH analysis using dChip revealed concordance of mainly large regions, but showed numerous, small nonoverlapping regions and LOH escaping detection. Evaluation of baseline variation and copy-number ratio response showed the best performance for the Agilent platform and confirmed the robustness of BAC arrays. Accordingly, these platforms demonstrated a higher degree of platform-specific CNAs. The SNP arrays displayed higher technical variation, although this was compensated by high density of elements. Affymetrix detected a higher degree of CNAs compared to Illumina, while the latter showed a lower noise level and higher detection rate in the LOH analysis. Large-scale studies of genomic aberrations are now feasible, but new tools for LOH analysis are requested.
  • Gustavsson, Peter, et al. (författare)
  • Duplication 16q12.1-q22.1 characterized by array CGH in a girl with spina bifida
  • 2007
  • Ingår i: European Journal of Medical Genetics. - Elsevier. - 1769-7212. ; 50:3, s. 237-241
  • Tidskriftsartikel (refereegranskat)abstract
    • We report a 7-year-old girl with spina bifida carrying a complex chromosome abnormality resulting in duplication 16q 12.1 -q22.1. An abnormal karyotype was identified involving the long arm of chromosome 11. and fluorescent in, situ hybridization (FISH) to metaphase chromosomes revealed an insertion of part of chromosome 16 on chromosome 11. A detailed mapping of the chromosome abnormality using whole genome array based comparative genomic hybridization (CGH) of the patient DNA revealed a duplication 16q12.1-q22.1 corresponding to gain of 19.8 Mb of DNA without any detectable loss of genetic material on chromosome 11. The karyotype is defined as 46,XX,der(11)ins(11; 16)(q13;q12.1 q22.1). We present here the clinical findings and a fine mapping of the associated structural chromosome abnormalities. We suggest that a gene dosage imbalance of 16q111-q22.1 is associated with spina bifida in the patient. (c) 2007 Elsevier Masson SAS. All rights reserved.
  • Karppinen, S. -M., et al. (författare)
  • Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies
  • 2006
  • Ingår i: Journal of Medical Genetics. - BMJ Publishing Group. - 0022-2593. ; 43:11, s. 856-862
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: BARD1 was originally identified as a BRCA1- interacting protein but has also been described in tumour-suppressive functions independent of BRCA1. Several studies have indicated that the BARD1 gene is a potential target for germline changes predisposing to breast and ovarian cancer. The C- terminal Cys557Ser change has previously been uncovered to associate with an increased risk of breast cancer and was recently shown to result in defective apoptotic activities. Aim and methods: Conformation- sensitive gel electrophoresis, minisequencing, TaqMan assays, denaturing high- performance liquid chromatography analysis and DNA sequencing were used to investigate the prevalence of the Cys557Ser allele in a large Nordic case - control study cohort consisting of 2906 patients with breast or ovarian cancer, 734 with prostate cancer, 188 with colorectal cancer, 128 men with breast cancer, and 3591 controls from Finland, Iceland, Denmark, Sweden and Norway. Results: The frequency of the BARD1 Cys557Ser variant seemed to increase among patients from families with breast or ovarian cancer lacking BRCA1 or BRCA2 mutations: a significant difference was obtained compared with controls ( 6.8% v 2.7%; p < 0.001; odds ratio ( OR) 2.6; 95% confidence interval (CI) 1.7 to 4.0) and with patients from BRCA1/ BRCA2 mutation- positive families ( 6.8% v 2.2%; p = 0.01; OR 3.2; 95% CI 1.2 to 8.3). In contrast, no major association with male breast, ovarian, colorectal or prostate cancer was observed. Additionally, a novel BARD1 allele resulting in Ser558Pro was identified in familial breast cancer cases. Conclusion: These results provide further evidence that BARD1 Cys557Ser confers a slightly increased risk of breast cancer in women.
  • Kuchinskaya, Ekaterina, et al. (författare)
  • Array-CGH reveals hidden gene dose changes in children with acute lymphoblastic leukaemia and a normal or failed karyotype by G-banding
  • 2008
  • Ingår i: British Journal of Haematology. - Federation of European Neuroscience Societies and Blackwell Publishing Ltd. - 0007-1048. ; 140:5, s. 572-577
  • Tidskriftsartikel (refereegranskat)abstract
    • A tiling path 33K BAC array was used to study 28 children with acute lymphoblastic leukaemia (ALL) who had normal or failed G-banded karyotypes. Twenty-two patients (79%) had a total of 135 copy number alterations (CNA) (69 gains and 66 losses); most of these patients showed CNA that were below the resolution of G-banding. Molecular cytogenetic and array comparative genomic hybridization results enabled the division of B-precursor ALL patients into five groups: high hyperdiploidy, intrachromosomal amplification of 21q, ETV6/RUNX1 rearrangement, others and no CNA. Apart from a shared deletion of 9p21.3, T-ALL patients had additional small CNA, with no region in common.
Skapa referenser, mejla, bekava och länka
fritt online (28)
Typ av publikation
tidskriftsartikel (85)
konferensbidrag (5)
rapport (1)
Typ av innehåll
refereegranskat (85)
övrigt vetenskapligt (6)
Borg, Åke, (86)
Staaf, Johan, (26)
Olsson, Håkan, (18)
Borg, A, (18)
Vallon-Christersson, ... (11)
Jönsson, Göran B, (10)
visa fler...
Bendahl, Pär Ola, (9)
Höglund, Mattias, (9)
Johansson, Bertil, (8)
Nilbert, Mef, (8)
Jernström, Helena (8)
Lindgren, David, (7)
Ringnér, Markus, (7)
Törngren, Therese, (7)
Fioretos, Thoas, (6)
Edén, Patrik, (5)
Saal, Lao, (5)
Gruvberger, Sofia, (5)
Schoumans, Jacquelin ... (5)
Liedberg, Fredrik, (4)
Gudjonsson, Sigurdur ... (4)
Nordenskjold, M, (4)
Rosenquist, Richard, (4)
Olsson, Eleonor, (4)
Krogh, Morten, (4)
Rydholm, Anders, (4)
Andersson, Anna, (4)
Månsson, Wiking (4)
Borg, Ake (4)
Kvist, Anders (4)
Fernebro, Josefin, (4)
Rovira, Carlos, (4)
Malmström, Per, (3)
Fernö, Mårten, (3)
Paulsson, Kajsa, (3)
Baldetorp, Bo, (3)
Mertens, Fredrik, (3)
Radice, P (3)
Manoukian, S (3)
Juliusson, Gunnar (3)
Medstrand, Patrik (3)
Barbaro, Michela (3)
Schoumans, J, (3)
Nordgren, Ann (3)
Strömbeck, Bodil, (3)
Loman, Niklas, (3)
Syrjakoski, K (3)
Mandahl, Nils, (3)
Hegardt, Cecilia, (3)
Bågeman, Erika, (3)
visa färre...
Lunds universitet (87)
Karolinska Institutet (22)
Uppsala universitet (9)
Linköpings universitet (3)
Göteborgs universitet (2)
Umeå universitet (2)
visa fler...
Stockholms universitet (2)
Linnéuniversitetet (1)
visa färre...
Engelska (90)
Polska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (87)
Naturvetenskap (3)
Samhällsvetenskap (2)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy